Trastuzumab Produces Therapeutic Actions by Upregulating miR-26a and miR-30b in Breast Cancer Cells

OBJECTIVE: Trastuzumab has been used for the treatment of HER2-positive breast cancer (BC). However, a subset of BC patients exhibited resistance to trastuzumab therapy. Thus, clarifying the molecular mechanism of trastuzumab treatment will be beneficial to improve the treatment of HER2-positive BC...

Descripción completa

Detalles Bibliográficos
Autores principales: Ichikawa, Takehiro, Sato, Fumiaki, Terasawa, Kazuya, Tsuchiya, Soken, Toi, Masakazu, Tsujimoto, Gozoh, Shimizu, Kazuharu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2012
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3288043/
https://www.ncbi.nlm.nih.gov/pubmed/22384020
http://dx.doi.org/10.1371/journal.pone.0031422

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3288043/
https://www.ncbi.nlm.nih.gov/pubmed/22384020
http://dx.doi.org/10.1371/journal.pone.0031422

Ejemplares similares